Intensive glucose control and the clinical paradox of transient progression of diabetic retinopathy: Prioritising the relevance of eye screening intervals
Restricted accessLetterFirst published online June, 2024
Intensive glucose control and the clinical paradox of transient progression of diabetic retinopathy: Prioritising the relevance of eye screening intervals
VaradhanLJoseMHumphreysT, et al. Newer treatments for diabetes mellitus: a caveat with rapid glycaemic improvement and caution regarding changes in retinopathy screening guidelines within the UK NHS programme. J R Coll Phys Edinb. Epub ahead of print 2024.
2.
TecceNCennamoGRinaldiM, et al. Exploring the impact of glycemic control on diabetic retinopathy: emerging models and prognostic implications. J Clin Med2024; 13: 831.
3.
ChewEYMillsJLMetzgerBE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care1995; 18: 631–637.
4.
MurphyRJiangYBoothM, et al. Progression of diabetic retinopathy after bariatric surgery. Diabet Med2015; 32: 1212–1220.
5.
AravindhanAFenwickEKChanAWD, et al. Extending the diabetic retinopathy screening intervals in Singapore: methodology and preliminary findings of a cohort study. BMC Public Health2024; 24: 786.
6.
ScanlonPH.Improving the screening of risk factors in diabetic retinopathy. Expert Rev Endocrinol Metab2022; 17: 235–243.
